- Corporate Officers - H
- Henderson Jeffrey William
Insider Trading History of Henderson Jeffrey William
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henderson Jeffrey William since 2011.
This trader's CIK number is 1324015.
At the time of last reporting, Henderson Jeffrey William was the Officer of Halozyme Therapeutics, Inc.. (stock ticker symbol HALO).
Also see all insider trading activities at Halozyme Therapeutics, Inc..
Note that in the past
Henderson Jeffrey William also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Fibrogen Inc (FGEN) by Henderson Jeffrey William
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | FGEN | 0 | $0 | 13,000 | $132,220 | 0 | $0 |
Yearly summary of insider trading at Qualcomm Inc/de (QCOM) by Henderson Jeffrey William
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | QCOM | 0 | $0 | 0 | $0 | 1,901 | $0 |
| 2023 | QCOM | 0 | $0 | 5,000 | $620,599 | 3,316 | $0 |
| 2022 | QCOM | 0 | $0 | 0 | $0 | 4,559 | $0 |
| 2021 | QCOM | 0 | $0 | 0 | $0 | 4,134 | $0 |
| 2020 | QCOM | 0 | $0 | 6,000 | $846,600 | 4,644 | $0 |
| 2019 | QCOM | 0 | $0 | 0 | $0 | 5,099 | $0 |
| 2018 | QCOM | 0 | $0 | 0 | $0 | 795 | $0 |
Yearly summary of insider trading at Cardinal Health Inc (CAH) by Henderson Jeffrey William
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | CAH | 0 | $0 | 273,960 | $19,224,574 | 184,550 | $7,798,631 |
| 2013 | CAH | 0 | $0 | 494,783 | $24,044,782 | 541,613 | $18,988,830 |
| 2012 | CAH | 0 | $0 | 125,636 | $4,892,210 | 100,000 | $2,729,000 |
| 2011 | CAH | 0 | $0 | 116,889 | $5,156,398 | 106,339 | $4,219,530 |
Yearly summary of insider trading at Halozyme Therapeutics, Inc. (HALO) by Henderson Jeffrey William
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | HALO | 0 | $0 | 20,503 | $1,105,772 | 0 | $0 |
| 2023 | HALO | 0 | $0 | 20,000 | $962,200 | 0 | $0 |
| 2020 | HALO | 0 | $0 | 24,498 | $981,757 | 0 | $0 |
Yearly summary of insider trading at Becton Dickinson & Co (BDX) by Henderson Jeffrey William
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | BDX | 1,500 | $350,430 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Henderson Jeffrey William:
1. Fibrogen Inc (FGEN)
2. Qualcomm Inc/de (QCOM)
3. Cardinal Health Inc (CAH)
4. Halozyme Therapeutics, Inc. (HALO)
5. Becton Dickinson & Co (BDX)
Table 1. Insider trading of Fibrogen Inc (FGEN) by Henderson Jeffrey William
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-09-01 | FGEN | Sale | 2,000 | 1.03 | 2,060 |
| 2023-08-04 | FGEN | Sale | 2,000 | 1.91 | 3,820 |
| 2023-07-11 | FGEN | Sale | 2,000 | 2.69 | 5,380 |
| 2023-06-08 | FGEN | Sale | 7,000 | 17.28 | 120,960 |
Table 2. Insider trading of Qualcomm Inc/de (QCOM) by Henderson Jeffrey William
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-03-09 | QCOM | Option Ex | 1,901 | .00 | 0 |
| 2023-03-10 | QCOM | Option Ex | 3,316 | .00 | 0 |
| 2023-02-22 | QCOM | Sale | 2,500 | 124.05 | 310,132 |
| 2023-02-23 | QCOM | Sale | 2,500 | 124.19 | 310,467 |
| 2022-03-12 | QCOM | Option Ex | 4,559 | .00 | 0 |
| 2021-04-05 | QCOM | Option Ex | 4,134 | .00 | 0 |
| 2020-11-10 | QCOM | Sale | 6,000 | 141.10 | 846,600 |
| 2020-03-10 | QCOM | Option Ex | 4,644 | .00 | 0 |
| 2019-03-08 | QCOM | Option Ex | 5,099 | .00 | 0 |
| 2018-03-22 | QCOM | Option Ex | 795 | .00 | 0 |
Table 3. Insider trading of Cardinal Health Inc (CAH) by Henderson Jeffrey William
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-08-27 | CAH | Option Ex | 26,567 | 51.49 | 1,367,934 |
| 2014-08-27 | CAH | Sale | 26,567 | 72.63 | 1,929,561 |
| 2014-08-18 | CAH | Option Ex | 64,058 | 40.70 | 2,607,480 |
| 2014-08-18 | CAH | Sale | 78,637 | 72.06 | 5,666,582 |
| 2014-08-08 | CAH | Option Ex | 93,925 | 40.70 | 3,823,217 |
| 2014-08-08 | CAH | Sale | 118,093 | 69.72 | 8,233,443 |
| 2014-07-14 | CAH | Sale | 23,632 | 70.65 | 1,669,600 |
| 2014-05-07 | CAH | Sale | 27,031 | 63.83 | 1,725,388 |
| 2013-08-13 | CAH | Option Ex | 56,007 | 49.25 | 2,758,344 |
| 2013-08-13 | CAH | Sale | 54,590 | 51.99 | 2,838,134 |
| 2013-07-26 | CAH | Sale | 76,781 | 50.99 | 3,915,063 |
| 2013-07-26 | CAH | Option Ex | 100,000 | 27.29 | 2,729,000 |
| 2013-07-18 | CAH | Sale | 57,623 | 49.99 | 2,880,573 |
| 2013-07-18 | CAH | Option Ex | 58,379 | 48.58 | 2,836,051 |
| 2013-07-15 | CAH | Option Ex | 14,853 | 48.58 | 721,558 |
| 2013-07-15 | CAH | Sale | 14,660 | 49.99 | 732,853 |
| 2013-07-11 | CAH | Sale | 83,211 | 48.99 | 4,076,506 |
| 2013-07-11 | CAH | Option Ex | 106,843 | 27.29 | 2,915,745 |
| 2013-05-06 | CAH | Option Ex | 205,531 | 34.20 | 7,028,132 |
| 2013-05-06 | CAH | Sale | 207,918 | 46.18 | 9,601,653 |
| 2012-10-04 | CAH | Option Ex | 50,000 | 27.29 | 1,364,500 |
| 2012-10-04 | CAH | Sale | 46,226 | 40.00 | 1,849,040 |
| 2012-09-10 | CAH | Sale | 77,081 | 38.29 | 2,951,431 |
| 2012-09-10 | CAH | Option Ex | 50,000 | 27.29 | 1,364,500 |
| 2012-09-07 | CAH | Sale | 2,329 | 39.39 | 91,739 |
| 2011-05-19 | CAH | Option Ex | 47,304 | 39.68 | 1,877,022 |
| 2011-05-19 | CAH | Sale | 57,854 | 45.25 | 2,617,893 |
| 2011-04-26 | CAH | Option Ex | 59,035 | 39.68 | 2,342,508 |
| 2011-04-26 | CAH | Sale | 59,035 | 43.00 | 2,538,505 |
Table 4. Insider trading of Halozyme Therapeutics, Inc. (HALO) by Henderson Jeffrey William
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-04-01 | HALO | Sale | 503 | 64.05 | 32,217 |
| 2025-03-03 | HALO | Sale | 5,000 | 58.52 | 292,625 |
| 2025-02-03 | HALO | Sale | 5,000 | 56.17 | 280,870 |
| 2025-01-06 | HALO | Sale | 10,000 | 50.01 | 500,060 |
| 2023-03-01 | HALO | Sale | 10,000 | 47.71 | 477,100 |
| 2023-02-28 | HALO | Sale | 10,000 | 48.51 | 485,100 |
| 2020-11-25 | HALO | Sale | 24,498 | 40.08 | 981,757 |
Table 5. Insider trading of Becton Dickinson & Co (BDX) by Henderson Jeffrey William
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-10 | BDX | Buy | 1,500 | 233.62 | 350,430 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Henderson Jeffrey William
(Officer of Halozyme Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.